Efficacy analysis following polymer coated drug eluting stent and bare metal stent deployment for femoropopliteal arterial disease.

ABSTRACT:

Objectives

The objective is to assess the performance of the Eluvia polymer coated drug eluting stent (DES) compared to a bare metal stent (BMS) platform in patients with femoropopliteal arterial disease.

Methods

This is a retrospective, single-center analysis. Patients treated with the Eluvia DES (group Eluvia) or the EverFlex BMS (group BMS) for femoropopliteal disease between January 2013 and December 2019 were included. Primary measure outcome of this analysis was the overall mortality. The PTX specific mortality, the primary patency, the amputation free survival (AFS), and the target lesion revascularization (TLR) rates were additionally evaluated.

Results

A total of 124 patients were treated by BMS deployment, while the Eluvia platform was preferred in 75 subjec

SUBMITTER: Shehada Y 

PROVIDER: S-EPMC10838477 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature